Clinical trial · Interventional
Nutritional Support During Induction Therapy for Esophageal Cancer
Nutritional Support in Patient Undergoing Induction Therapy for Esophageal Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Patients diagnosed with esophageal cancer have difficulty eating, as the food pipe becomes obstructed by the cancer. This may impair the ability for the patient to receive appropriate calorie intake, especially during administration of chemotherapy and radiation therapy given prior to surgical resection. A strategy is to place a feeding tube directly in the stomach or in the small bowel to have an access to the patient's gastrointestinal tract during administration of chemo radiation therapy. However, these feeding tubes may lead to adverse events, including dislodgement, infection, the tube may be plugged, etc. If these complications were to happen, patients may have their treatment delayed, may have to come to the emergency department or even be admitted. In some cases, patients may need to have a surgery performed to treat the complication. Most centres in Canada have moved away from placement of these feeding tubes due to the high incidence of complications associated with the feeding tubes placement, and due to the high efficacy from the chemoradiation therapy in shrinking the tumour, allowing for the patient to swallow. In London, the preference from the Medical and Radiation Oncologists was to have these feeding tubes placed to avoid delay in treating the patients. There is therefore significant controversy as to what is the best approach in this patient population. Our goal is to run a feasibility randomized controlled trial studying this question.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Esophageal Cancer | Malignant Esophageal Neoplasm | CURATED_EXACT | 0.92 |
| Nutrition Aspect of Cancer | Esophageal Neoplasm | PROBABILISTIC | 0.70 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No feeding tube placed | Procedure | — | UNRESOLVED |
| Placement of a percutaneous feeding tube | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Percutaneous enteral access
- description
- Feeding tube, either gastrostomy (G-) tube or gastrojejunostomy (GJ-) tube (placed by Interventional Radiology) or J-tube (surgically placed)
- interventionNames
- Procedure: Placement of a percutaneous feeding tube
- type
- EXPERIMENTAL
- label
- No percutaneous enteral access
- description
- No feeding tube placed.
- interventionNames
- Procedure: No feeding tube placed
Primary outcomes (1)
- measure
- Feasibility of the trial
- timeFrame
- From randomization to 90-day post-operative
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adult patient * Non-cervical biopsy-proven esophageal or gastroesophageal junction (Siewert I or II) cancer * Patient eligible for induction therapy then esophagectomy (stage Ib to III) Exclusion Criteria: * Impossibility to pass an endoscope beyond the tumour * metastatic disease * early-stage disease with either upfront esophagectomy or endoscopic resection planned * patient refusal of the feeding tube * inability to swallow their pill * inability to tolerate a full fluid diet
References
Publications (0)
Data not yet available